Some Patients May Experience Durable Disease Control Even After Discontinuing Immune Checkpoint Inhibitors for Side Effects
PHILADELPHIA – A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy...